Anil Singhal MD

Physician

1011 Honor Heights DrMuskogee, OK 74401
Phone+1 918-577-3783
Fax+1 918-577-3833

Join Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 7 invites waiting!
Read the latest clinical news, personalized to your specialty.

Join Doximity Already have an account?

Summary

Dr. Anil Singhal, MD is a neurologist in Muskogee, Oklahoma. He is currently licensed to practice medicine in Georgia and Illinois. He is affiliated with Jack C. Montgomery Department of Veterans Affairs Medical Center.

Education & Training

Emory University School of MedicineResidency, Neurology, 2024 - 2027
Gajra Raja Medical CollegeClass of 1984

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

IL State Medical License 1982 - 2026
GA State Medical License 2001 - 2003

Publications & Presentations

PubMed

119 citations
Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study.
Meletios A. Dimopoulos, Sagar Lonial, Darrell White, Philippe Moreau, Katja Weisel
Blood Cancer Journal. 2020-09-04
197 citations
Randomized phase 2 study: elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM
Andrzej Jakubowiak, Massimo Offidani, Brigitte Pegourie, Javier de la Rubia, Laurent Garderet
Blood. 2016-06-09
131 citations
Elotuzumab in combination with lenalidomide and dexamethasone in patients with relapsed multiple myeloma: final phase 2 results from the randomised, open-label, phase ...
Paul G. Richardson, Sundar Jagannath, Philippe Moreau, Andrzej Jakubowiak, Marc S. Raab
The Lancet. Haematology. 2015-12-01